High-dose methylprednisolone in video-assisted thoracoscopic surgery lobectomy: A randomized controlled trial

Lars S. Bjerregaard; Per F. Jensen; Dennis R. Bigler; René Horsleben Petersen; Hasse Møller-Sørensen; Kaj Gefke; Henrik J. Hansen; Henrik Kehlet

doi:10.1093/ejcts/ezx248

High-dose methylprednisolone in video-assisted thoracoscopic surgery lobectomy: A randomized controlled trial

Lars S. Bjerregaard^*, Per F. Jensen, Dennis R. Bigler, René Horsleben Petersen, Hasse Møller-Sørensen, Kaj Gefke, Henrik J. Hansen, Henrik Kehlet

^*Corresponding author for this work

Department of Clinical Medicine

10 Citations (Scopus)

Abstract

OBJECTIVES: The optimal postoperative analgesic strategy after video-assisted thoracoscopic surgery lobectomy remains undetermined. We hypothesized that high-dose preoperative methylprednisolone (MP) would improve analgesia compared to placebo. METHODS: A total of 120 adult patients were randomized equally to 125mg MP or placebo before the start of their elective videoassisted thoracoscopic surgery lobectomy. Group allocation was blinded to patients, investigators and caregivers, and all patients received standardized multimodal, opioid-sparing analgesia. Our primary outcome was area under the curve on a numeric rating scale from 0 to 10, for pain scores on the day of surgery and on postoperative days 1 and 2. Clinical follow-up was 2-3 weeks, and telephone follow-up was 12 weeks after surgery. RESULTS: Ninety-six patients were included in the primary analysis. Methylprednisolone significantly decreased median pain scores on the day of surgery: at rest (numeric rating scale 1.6 vs 2.0, P = 0.019) and after mobilization to a sitting position (numeric rating scale 1.7 vs 2.5, P = 0.004) but not during arm abduction and coughing (P = 0.052 and P = 0.083, respectively). Nausea and fatigue were reduced on the day of surgery (P = 0.04 and 0.03), whereas no outcome was improved on postoperative Days 1 and 2. Methylprednisolone did not increase the risk of complications but increased blood glucose levels on the day of surgery (P < 0.0001). CONCLUSIONS: High-dose preoperative MP significantly reduced pain at rest and after mobilization to a sitting position on the day of surgery, without later analgesic effects. Nausea and fatigue were improved without side effects, except transient higher postoperative blood glucose levels.

Original language	English
Journal	European Journal of Cardio-Thoracic Surgery
Volume	53
Issue number	1
Pages (from-to)	209-215
Number of pages	7
ISSN	1010-7940
DOIs	https://doi.org/10.1093/ejcts/ezx248
Publication status	Published - 2018

Keywords

Methylprednisolone
Pain
Postoperative
Steroids
Video assisted thaoracic surgery

Access to Document

10.1093/ejcts/ezx248

ezx248.pdfFinal published version, 389 KB

https://academic.oup.com/ejcts/article-pdf/53/1/209/22547339/ezx248.pdf

Cite this

@article{112b9ab187f94fc98f044f9ad4ef919a,

title = "High-dose methylprednisolone in video-assisted thoracoscopic surgery lobectomy: A randomized controlled trial",

abstract = "OBJECTIVES: The optimal postoperative analgesic strategy after video-assisted thoracoscopic surgery lobectomy remains undetermined. We hypothesized that high-dose preoperative methylprednisolone (MP) would improve analgesia compared to placebo. METHODS: A total of 120 adult patients were randomized equally to 125mg MP or placebo before the start of their elective videoassisted thoracoscopic surgery lobectomy. Group allocation was blinded to patients, investigators and caregivers, and all patients received standardized multimodal, opioid-sparing analgesia. Our primary outcome was area under the curve on a numeric rating scale from 0 to 10, for pain scores on the day of surgery and on postoperative days 1 and 2. Clinical follow-up was 2-3 weeks, and telephone follow-up was 12 weeks after surgery. RESULTS: Ninety-six patients were included in the primary analysis. Methylprednisolone significantly decreased median pain scores on the day of surgery: at rest (numeric rating scale 1.6 vs 2.0, P = 0.019) and after mobilization to a sitting position (numeric rating scale 1.7 vs 2.5, P = 0.004) but not during arm abduction and coughing (P = 0.052 and P = 0.083, respectively). Nausea and fatigue were reduced on the day of surgery (P = 0.04 and 0.03), whereas no outcome was improved on postoperative Days 1 and 2. Methylprednisolone did not increase the risk of complications but increased blood glucose levels on the day of surgery (P < 0.0001). CONCLUSIONS: High-dose preoperative MP significantly reduced pain at rest and after mobilization to a sitting position on the day of surgery, without later analgesic effects. Nausea and fatigue were improved without side effects, except transient higher postoperative blood glucose levels.",

keywords = "Methylprednisolone, Pain, Postoperative, Steroids, Video assisted thaoracic surgery",

author = "Bjerregaard, {Lars S.} and Jensen, {Per F.} and Bigler, {Dennis R.} and Petersen, {Ren{\'e} Horsleben} and Hasse M{\o}ller-S{\o}rensen and Kaj Gefke and Hansen, {Henrik J.} and Henrik Kehlet",

year = "2018",

doi = "10.1093/ejcts/ezx248",

language = "English",

volume = "53",

pages = "209--215",

journal = "European Journal of Cardio-Thoracic Surgery",

issn = "1010-7940",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - High-dose methylprednisolone in video-assisted thoracoscopic surgery lobectomy

T2 - A randomized controlled trial

AU - Bjerregaard, Lars S.

AU - Jensen, Per F.

AU - Bigler, Dennis R.

AU - Petersen, René Horsleben

AU - Møller-Sørensen, Hasse

AU - Gefke, Kaj

AU - Hansen, Henrik J.

AU - Kehlet, Henrik

PY - 2018

Y1 - 2018

N2 - OBJECTIVES: The optimal postoperative analgesic strategy after video-assisted thoracoscopic surgery lobectomy remains undetermined. We hypothesized that high-dose preoperative methylprednisolone (MP) would improve analgesia compared to placebo. METHODS: A total of 120 adult patients were randomized equally to 125mg MP or placebo before the start of their elective videoassisted thoracoscopic surgery lobectomy. Group allocation was blinded to patients, investigators and caregivers, and all patients received standardized multimodal, opioid-sparing analgesia. Our primary outcome was area under the curve on a numeric rating scale from 0 to 10, for pain scores on the day of surgery and on postoperative days 1 and 2. Clinical follow-up was 2-3 weeks, and telephone follow-up was 12 weeks after surgery. RESULTS: Ninety-six patients were included in the primary analysis. Methylprednisolone significantly decreased median pain scores on the day of surgery: at rest (numeric rating scale 1.6 vs 2.0, P = 0.019) and after mobilization to a sitting position (numeric rating scale 1.7 vs 2.5, P = 0.004) but not during arm abduction and coughing (P = 0.052 and P = 0.083, respectively). Nausea and fatigue were reduced on the day of surgery (P = 0.04 and 0.03), whereas no outcome was improved on postoperative Days 1 and 2. Methylprednisolone did not increase the risk of complications but increased blood glucose levels on the day of surgery (P < 0.0001). CONCLUSIONS: High-dose preoperative MP significantly reduced pain at rest and after mobilization to a sitting position on the day of surgery, without later analgesic effects. Nausea and fatigue were improved without side effects, except transient higher postoperative blood glucose levels.

AB - OBJECTIVES: The optimal postoperative analgesic strategy after video-assisted thoracoscopic surgery lobectomy remains undetermined. We hypothesized that high-dose preoperative methylprednisolone (MP) would improve analgesia compared to placebo. METHODS: A total of 120 adult patients were randomized equally to 125mg MP or placebo before the start of their elective videoassisted thoracoscopic surgery lobectomy. Group allocation was blinded to patients, investigators and caregivers, and all patients received standardized multimodal, opioid-sparing analgesia. Our primary outcome was area under the curve on a numeric rating scale from 0 to 10, for pain scores on the day of surgery and on postoperative days 1 and 2. Clinical follow-up was 2-3 weeks, and telephone follow-up was 12 weeks after surgery. RESULTS: Ninety-six patients were included in the primary analysis. Methylprednisolone significantly decreased median pain scores on the day of surgery: at rest (numeric rating scale 1.6 vs 2.0, P = 0.019) and after mobilization to a sitting position (numeric rating scale 1.7 vs 2.5, P = 0.004) but not during arm abduction and coughing (P = 0.052 and P = 0.083, respectively). Nausea and fatigue were reduced on the day of surgery (P = 0.04 and 0.03), whereas no outcome was improved on postoperative Days 1 and 2. Methylprednisolone did not increase the risk of complications but increased blood glucose levels on the day of surgery (P < 0.0001). CONCLUSIONS: High-dose preoperative MP significantly reduced pain at rest and after mobilization to a sitting position on the day of surgery, without later analgesic effects. Nausea and fatigue were improved without side effects, except transient higher postoperative blood glucose levels.

KW - Methylprednisolone

KW - Pain

KW - Postoperative

KW - Steroids

KW - Video assisted thaoracic surgery

U2 - 10.1093/ejcts/ezx248

DO - 10.1093/ejcts/ezx248

M3 - Journal article

C2 - 28977390

AN - SCOPUS:85046128865

SN - 1010-7940

VL - 53

SP - 209

EP - 215

JO - European Journal of Cardio-Thoracic Surgery

JF - European Journal of Cardio-Thoracic Surgery

IS - 1

ER -

High-dose methylprednisolone in video-assisted thoracoscopic surgery lobectomy: A randomized controlled trial

Abstract

Keywords

Access to Document

Fingerprint

Cite this